Table 1.
Admission |
Discharge |
|||||||
---|---|---|---|---|---|---|---|---|
Covariates | Cohort | Men | Women | P value | Cohort | Men | Women | P value |
Number Patients | 2,278 | 1,357 | 921 | – | 970 | 592 | 378 | – |
Age (Years) | 61 (21.0) | 61 (20.0) | 60 (23.0) | 0.748 | 61 (19.0) | 61 (16.25) | 60 (23.00) | 0.339 |
CCI∗ | 1.0 (3.0) | 1 (3.0) | 1 (2.0) | 0.248 | 1.0 (2.0) | 1.0 (2.0) | 1.0 (2.0) | 0.405 |
Arrest out-of-hospital (%) | 1748 (76.73) | 1028 (75.76) | 720 (78.18) | 0.197 | 702 (72.47) | 424 (71.62) | 279 (73.81) | 0.503 |
Initial VT/VFa (%) | 772 (33.89) | 497 (36.62) | 275 (29.86) | 0.001 | 490 (50.52) | 316 (53.38) | 174 (46.03) | 0.030 |
Etiology (%) | < 0.001 | 0.001 | ||||||
ACSb | 353 (15.50) | 239 (17.61) | 114 (12.38) | – | 219 (22.58) | 159 (26.86) | 60 (15.87) | – |
Respiratory | 341 (14.97) | 169 (12.45) | 172 (18.68) | – | 121 (12.47) | 67 (11.32) | 54 (14.29) | – |
Other cardiacc | 371 (16.29) | 229 (16.88) | 142 (15.42) | – | 218 (22.47) | 125 (21.11) | 93 (24.60) | – |
Other non cardiacd | 642 (28.18) | 365 (26.90) | 277 (30.08) | – | 242 (24.95) | 134 (22.64) | 108 (28.57) | – |
Unknown | 571 (25.07) | 355 (26.16) | 216 (23.45) | – | 170 (17.53) | 107 (18.07) | 63 (16.67) | – |
Arrest duration (Minutes) | 12 (21.0) | 12 (21.0) | 13 (21.0) | 0.841 | 8 (12.5) | 8 (12.0) | 6.5 (13.0) | 0.863 |
Bystander CPRe (%) | 1108 (48.64) | 664 (48.93) | 444 (48.21) | 0.752 | 413 (42.58) | 259 (43.75) | 154 (40.74) | 0.148 |
Witnessed (%) | 1025 (45.02) | 624 (45.98) | 401 (43.59) | 0.526 | 419 (43.20) | 270 (45.61) | 149 (39.42) | 0.159 |
Epinephrine (Number of doses) | 2 (3.0) | 2 (3.0) | 2 (3.0) | 0.248 | 1 (2.0) | 1 (2.0) | 1 (2.0) | 0.578 |
PCACf (%) | 0.105 | 0.374 | ||||||
1 | 534 (25.99) | 318 (25.75) | 216 (26.34) | – | 463 (52.14) | 274 (50.46) | 189 (54.78) | – |
2 | 399 (19.42) | 261 (21.13) | 138 (16.83) | – | 267 (30.07) | 174 (32.04) | 93 (26.96) | – |
3 | 204 (9.93) | 117 (9.47) | 87 (10.61) | – | 93 (10.47) | 58 (10.68) | 35 (10.14) | v |
4 | 918 (44.67) | 539 (43.64) | 379 (46.22) | – | 65 (7.32) | 37 (6.81) | 28 (8.12) | – |
Catheterization (%) | 596 (26.16) | 390 (28.74) | 206 (22.37) | 0.001 | 412 (42.47) | 275 (46.45) | 137 (36.24) | 0.002 |
Temperature Treatment (%) | 0.695 | 0.565 | ||||||
36 °C | 644 (28.27) | 370 (27.27) | 274 (29.75) | – | 244 (25.15) | 147 (24.83) | 97 (25.66) | – |
33 °C | 767 (33.67) | 472 (34.78) | 295 (32.03) | – | 204 (21.03) | 135 (22.80) | 69 (18.25) | – |
Active Normothermia | 31 (1.36) | 18 (1.33) | 13 (1.41) | – | 13 (1.34) | 7 (1.18) | 6 (1.59) | – |
No TTMg | 694 (30.47) | 409 (30.14) | 285 (30.94) | – | 458 (47.22) | 270 (45.61) | 188 (49.74) | – |
Otherh | 142 (6.23) | 88 (6.48) | 54 (5.87) | – | 51 (5.26) | 33 (5.58) | 18 (4.76) | – |
Ventricular Tachycardia or Fibrillation.
Acute Coronary Syndrome.
Intrinsic arrythmia, arrythmia secondary to cardiomyopathy, structural heart disease, left ventricule failure, right ventricule failure.
Toxicological, airway obstruction, exsanguination, distributive shock, metabolic derangement.
Cardio Pulmonary resuscitation.
Pittsburgh Cardiac Arrest Category.
Other targeted temperature.
Temperature Treatment Management.
Charlson Comorbidity Index.